Melanie Senior


20 Years of Experience

About

Melanie is a reporter, commentator, and industry analyst within the biopharmaceutical and medtech industry. Melanie is a specialist within consulting across market access, pricing, outcomes-based care, precision medicine, digital health, AI, R&D strategies and consumer empowerment for a range of clients in biopharma and investment community. Her expertise is valued at Wharton Business School's Pharmaceutical Executive course training in the area of pricing and market access modules.

She is a speaker and presenter for corporate development and strategist teams and moderator at key industry events.

Melanie is a graduate of the University Of Cambridge with a Bachelor’s degree in Natural Science and has earned her Master degree from the University of Sheffield in International Health Technology Assessment, Pricing, and Reimbursement

Articles from Melanie Senior:

Providers & Payors

Value-Based Procurement in Europe: Not Just about Price

European buyers are becoming more organized. Hospital groups are banding together to achieve better pricing and value-for-money on high-volume equipment, health technology assessors have expanded their focus to devices, and several European countries use tender systems to select lower-cost providers. All of this impacts medical device firms.

Read Article